Published • loading... • Updated
Pioneer Study: Seniors Paid More for Key Drugs Despite Federal Price Controls
Summary by Pioneer Institute
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Pioneer Study: Seniors Paid More for Key Drugs Despite Federal Price Controls
Out-of-pocket costs rose in 2025 for widely used Medicare drugs targeted under Inflation Reduction Act BOSTON – Many Medicare seniors paid higher out-of-pocket costs in 2025 for widely used prescription drugs—despite a federal law intended to lower them, according to a new Pioneer Institute study. The analysis examines the first group of drugs selected under the Inflation Reduction Act’s (IRA) price negotiation program. While federally set “Ma…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
